XORTX Therapeutics Inc. - XRTX

About Gravity Analytica
Recent News
- 05.19.2025 - XORTX Announces USD $3 Million Offering
- 05.19.2025 - XORTX Announces USD $3 Million Offering
- 04.30.2025 - XORTX Provides Update on FDA Type B Meeting Request
- 04.30.2025 - XORTX Provides Update on FDA Type B Meeting Request
- 04.28.2025 - XORTX Announces Grant of European Patent
- 04.28.2025 - XORTX Announces Grant of European Patent
- 04.17.2025 - XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Recent Filings
- 05.19.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 05.19.2025 - EX-99.1 EX-99.1
- 05.16.2025 - EX-99.1 EX-99.1
- 05.16.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.12.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 05.01.2025 - NT 20-F Notification of inability to timely file Form 20-F
- 04.30.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 04.30.2025 - EX-99.1 EX-99.1
- 04.28.2025 - EX-99.1 EX-99.1